Stay updated with breaking news from Pressor Effects. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Results demonstrate KarXT was not associated with clinically meaningful increases in blood pressure in adults with schizophrenia KarXT demonstrated a mean change from baseline to week 8 in 24-hour...
PureTech's Karuna receives positive results from its KarXT blood pressure trial
Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced positive results from its Phase 1b open-label, eight-week inpatient trial evaluating the effect of ...